4D Molecular Therapeutics Growth Metrics (2020-2026)

EBITDA Margin Growth (1y) (Quarter)

0.04M

-0.16M

-2.90M

-0.13M

-1.75M

-0.36M

2.46M

-0.79M

0.41M

0.52M

19.52M

-12.61M

-83.57M

-170.43M

-580.46M

-24.68M

45.27M

163.64M

561.17M

38.06M

EBITDA Margin Growth (3y) (Quarter)

-0.97M

-1.30M

0.00M

19.08M

-13.54M

-84.91M

-170.27M

-558.48M

-38.08M

-37.88M

-6.27M

0.23M

0.77M

EBITDA Margin Growth (5y) (Quarter)

-38.26M

-39.59M

-6.79M

-0.21M

-0.16M

EBITDA Margin (QoQ) (Quarter)

0.08M

-0.16M

-2.53M

2.48M

-1.54M

1.22M

0.30M

-0.78M

-0.33M

1.34M

19.30M

-32.91M

-71.29M

-85.53M

-390.73M

522.87M

-1.34M

32.84M

6.80M

-0.24M

EBIT Margin Growth (1y) (Quarter)

0.04M

-0.16M

-2.90M

-0.13M

-1.75M

-0.36M

2.46M

-0.79M

0.41M

0.52M

19.52M

-12.61M

-83.57M

-170.43M

-580.46M

-24.68M

45.27M

163.64M

561.17M

38.06M

EBIT Margin Growth (3y) (Quarter)

-0.97M

-1.30M

0.00M

19.08M

-13.54M

-84.91M

-170.27M

-558.48M

-38.08M

-37.88M

-6.27M

0.23M

0.77M

EBIT Margin Growth (5y) (Quarter)

-38.26M

-39.59M

-6.79M

-0.21M

-0.16M

EBIT Margin (QoQ) (Quarter)

0.08M

-0.16M

-2.53M

2.48M

-1.54M

1.22M

0.30M

-0.78M

-0.33M

1.34M

19.30M

-32.91M

-71.29M

-85.53M

-390.73M

522.87M

-1.34M

32.84M

6.80M

-0.24M

EBT Margin Growth (1y) (Quarter)

0.04M

-0.15M

-2.93M

-0.13M

-1.73M

-0.35M

2.51M

-0.75M

0.49M

0.51M

17.20M

-10.61M

-68.58M

-146.14M

-513.49M

-22.75M

33.42M

139.82M

496.50M

34.09M

EBT Margin Growth (3y) (Quarter)

-0.92M

-1.20M

0.01M

16.78M

-11.49M

-69.81M

-145.98M

-493.77M

-34.10M

-34.66M

-5.80M

0.22M

0.74M

EBT Margin Growth (5y) (Quarter)

-34.28M

-36.35M

-6.31M

-0.21M

-0.14M

EBT Margin (QoQ) (Quarter)

0.08M

-0.16M

-2.56M

2.51M

-1.52M

1.22M

0.29M

-0.74M

-0.28M

1.23M

16.99M

-28.55M

-58.25M

-76.32M

-350.36M

462.19M

-2.08M

30.08M

6.32M

-0.23M

Enterprise Value Growth (1y) (Quarter)

10.46%

9.12%

1.09%

-40.85%

13.81%

15.12%

-28.73%

-40.38%

-34.97%

-162.36%

-74.63%

-57.01%

-47.41%

38.88%

45.89%

39.22%

5.23%

-21.61%

Enterprise Value Growth (3y) (Quarter)

-62.63%

-1.37%

-26.49%

-30.52%

-45.88%

-19.69%

-10.82%

-6.74%

-10.24%

-23.54%

-24.93%

Enterprise Value Growth (5y) (Quarter)

-53.63%

-7.79%

-8.51%

Enterprise Value (QoQ) (Quarter)

6.20%

33.67%

-53.26%

4.69%

-2.09%

5.55%

6.22%

6.13%

-54.82%

-3.00%

9.83%

-82.46%

-3.05%

7.39%

15.34%

24.35%

8.78%

-4.04%

-31.99%

2.92%

FCF Margin Growth (1y) (Quarter)

0.01M

-0.10M

-2.65M

-0.12M

-1.28M

-0.28M

2.29M

-0.75M

0.31M

0.40M

14.43M

-9.69M

-58.44M

-106.84M

-449.60M

-23.57M

30.13M

101.68M

435.35M

33.99M

FCF Margin Growth (3y) (Quarter)

-0.91M

-0.97M

0.02M

14.07M

-10.56M

-59.41M

-106.71M

-432.88M

-34.02M

-28.00M

-4.76M

0.19M

0.72M

FCF Margin Growth (5y) (Quarter)

-34.17M

-29.27M

-5.14M

-0.18M

-0.14M

FCF Margin (QoQ) (Quarter)

0.07M

-0.11M

-2.35M

2.28M

-1.10M

0.89M

0.22M

-0.77M

-0.04M

0.98M

14.25M

-24.89M

-48.78M

-47.42M

-328.51M

401.14M

4.92M

24.13M

5.16M

-0.23M

Net Margin Growth (1y) (Quarter)

0.04M

-0.15M

-2.94M

-0.13M

-1.73M

-0.35M

2.51M

-0.75M

0.49M

0.51M

17.21M

-10.61M

-68.67M

-146.14M

-513.70M

-22.69M

33.47M

139.82M

496.71M

34.04M

Net Margin Growth (3y) (Quarter)

-0.92M

-1.20M

0.01M

16.78M

-11.49M

-69.90M

-145.98M

-493.98M

-34.05M

-34.70M

-5.81M

0.22M

0.74M

Net Margin Growth (5y) (Quarter)

-34.23M

-36.40M

-6.31M

-0.21M

-0.14M

Net Margin (QoQ) (Quarter)

0.08M

-0.16M

-2.56M

2.51M

-1.52M

1.22M

0.29M

-0.74M

-0.28M

1.23M

17.00M

-28.56M

-58.33M

-76.24M

-350.57M

462.44M

-2.17M

30.12M

6.32M

-0.23M

Operating Margin Growth (1y) (Quarter)

0.04M

-0.16M

-2.90M

-0.13M

-1.75M

-0.36M

2.46M

-0.79M

0.41M

0.52M

19.52M

-12.61M

-83.57M

-170.43M

-580.46M

-24.68M

45.27M

163.64M

561.17M

38.06M

Operating Margin Growth (3y) (Quarter)

-0.97M

-1.30M

0.00M

19.08M

-13.54M

-84.91M

-170.27M

-558.48M

-38.08M

-37.88M

-6.27M

0.23M

0.77M

Operating Margin Growth (5y) (Quarter)

-38.26M

-39.59M

-6.79M

-0.21M

-0.16M

Operating Margin (QoQ) (Quarter)

0.08M

-0.16M

-2.53M

2.48M

-1.54M

1.22M

0.30M

-0.78M

-0.33M

1.34M

19.30M

-32.91M

-71.29M

-85.53M

-390.73M

522.87M

-1.34M

32.84M

6.80M

-0.24M

Return on Assets Growth (1y) (Quarter)

0.00M

Return on Assets Growth (3y) (Quarter)

0.00M

Return on Assets Growth (5y) (Quarter)

0.00M

Return on Assets (QoQ) (Quarter)

0.00M

Return on Capital Employed Growth (1y) (Quarter)

-239.00

-0.00M

-982.00

-0.00M

-716.00

719.00

909.00

0.00M

206.00

5.00

-0.00M

-138.00

361.00

Return on Capital Employed Growth (3y) (Quarter)

-330.00

-103.00

-56.00

-855.00

-0.00M

776.00

0.00M

Return on Capital Employed Growth (5y) (Quarter)

-0.00M

Return on Capital Employed (QoQ) (Quarter)

186.00

-770.00

293.00

52.00

-924.00

-403.00

-494.00

-397.00

579.00

0.00M

-305.00

821.00

414.00

-723.00

-506.00

-581.00

-812.00

-806.00

0.00M

-82.00

Return on Equity Growth (1y) (Quarter)

-1.00

0.00M

Return on Equity Growth (3y) (Quarter)

-1.00

0.00M

Return on Equity Growth (5y) (Quarter)

-1.00

0.00M

Return on Equity (QoQ) (Quarter)

0.00M

Return on Sales Growth (1y) (Quarter)

4.00

-15.00

-293.00

-13.00

-173.00

-35.00

251.00

-75.00

49.00

51.00

0.00M

-0.00M

-0.01M

-0.05M

-0.00M

0.00M

0.01M

0.05M

0.00M

Return on Sales Growth (3y) (Quarter)

-92.00

-120.00

1.00

0.00M

-0.00M

-0.01M

-0.05M

-0.00M

-580.00

22.00

74.00

Return on Sales Growth (5y) (Quarter)

-0.00M

-631.00

-21.00

-14.00

Return on Sales (QoQ) (Quarter)

8.00

-16.00

-256.00

251.00

-152.00

122.00

29.00

-74.00

-28.00

123.00

0.00M

-0.00M

-0.01M

-0.04M

0.05M

-208.00

0.00M

632.00

-23.00

Research Tools

Developers

4D Molecular Therapeutics Growth Metrics (2020-2026) | FDMT

Growth Metrics	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)	0.04M	-0.16M	-2.90M	-0.13M	-1.75M	-0.36M	2.46M	-0.79M	0.41M	0.52M	19.52M	-12.61M	-83.57M	-170.43M	-580.46M	-24.68M	45.27M	163.64M	561.17M	38.06M
EBITDA Margin Growth (3y) (Quarter)								-0.97M	-1.30M	0.00M	19.08M	-13.54M	-84.91M	-170.27M	-558.48M	-38.08M	-37.88M	-6.27M	0.23M	0.77M
EBITDA Margin Growth (5y) (Quarter)																-38.26M	-39.59M	-6.79M	-0.21M	-0.16M
EBITDA Margin (QoQ) (Quarter)	0.08M	-0.16M	-2.53M	2.48M	-1.54M	1.22M	0.30M	-0.78M	-0.33M	1.34M	19.30M	-32.91M	-71.29M	-85.53M	-390.73M	522.87M	-1.34M	32.84M	6.80M	-0.24M
EBIT Margin Growth (1y) (Quarter)	0.04M	-0.16M	-2.90M	-0.13M	-1.75M	-0.36M	2.46M	-0.79M	0.41M	0.52M	19.52M	-12.61M	-83.57M	-170.43M	-580.46M	-24.68M	45.27M	163.64M	561.17M	38.06M
EBIT Margin Growth (3y) (Quarter)								-0.97M	-1.30M	0.00M	19.08M	-13.54M	-84.91M	-170.27M	-558.48M	-38.08M	-37.88M	-6.27M	0.23M	0.77M
EBIT Margin Growth (5y) (Quarter)																-38.26M	-39.59M	-6.79M	-0.21M	-0.16M
EBIT Margin (QoQ) (Quarter)	0.08M	-0.16M	-2.53M	2.48M	-1.54M	1.22M	0.30M	-0.78M	-0.33M	1.34M	19.30M	-32.91M	-71.29M	-85.53M	-390.73M	522.87M	-1.34M	32.84M	6.80M	-0.24M
EBT Margin Growth (1y) (Quarter)	0.04M	-0.15M	-2.93M	-0.13M	-1.73M	-0.35M	2.51M	-0.75M	0.49M	0.51M	17.20M	-10.61M	-68.58M	-146.14M	-513.49M	-22.75M	33.42M	139.82M	496.50M	34.09M
EBT Margin Growth (3y) (Quarter)								-0.92M	-1.20M	0.01M	16.78M	-11.49M	-69.81M	-145.98M	-493.77M	-34.10M	-34.66M	-5.80M	0.22M	0.74M
EBT Margin Growth (5y) (Quarter)																-34.28M	-36.35M	-6.31M	-0.21M	-0.14M
EBT Margin (QoQ) (Quarter)	0.08M	-0.16M	-2.56M	2.51M	-1.52M	1.22M	0.29M	-0.74M	-0.28M	1.23M	16.99M	-28.55M	-58.25M	-76.32M	-350.36M	462.19M	-2.08M	30.08M	6.32M	-0.23M
Enterprise Value Growth (1y) (Quarter)			10.46%	9.12%	1.09%	-40.85%	13.81%	15.12%	-28.73%	-40.38%	-34.97%	-162.36%	-74.63%	-57.01%	-47.41%	38.88%	45.89%	39.22%	5.23%	-21.61%
Enterprise Value Growth (3y) (Quarter)							-62.63%				-1.37%	-26.49%	-30.52%	-45.88%	-19.69%	-10.82%	-6.74%	-10.24%	-23.54%	-24.93%
Enterprise Value Growth (5y) (Quarter)															-53.63%				-7.79%	-8.51%
Enterprise Value (QoQ) (Quarter)	6.20%	33.67%	-53.26%	4.69%	-2.09%	5.55%	6.22%	6.13%	-54.82%	-3.00%	9.83%	-82.46%	-3.05%	7.39%	15.34%	24.35%	8.78%	-4.04%	-31.99%	2.92%
FCF Margin Growth (1y) (Quarter)	0.01M	-0.10M	-2.65M	-0.12M	-1.28M	-0.28M	2.29M	-0.75M	0.31M	0.40M	14.43M	-9.69M	-58.44M	-106.84M	-449.60M	-23.57M	30.13M	101.68M	435.35M	33.99M
FCF Margin Growth (3y) (Quarter)								-0.91M	-0.97M	0.02M	14.07M	-10.56M	-59.41M	-106.71M	-432.88M	-34.02M	-28.00M	-4.76M	0.19M	0.72M
FCF Margin Growth (5y) (Quarter)																-34.17M	-29.27M	-5.14M	-0.18M	-0.14M
FCF Margin (QoQ) (Quarter)	0.07M	-0.11M	-2.35M	2.28M	-1.10M	0.89M	0.22M	-0.77M	-0.04M	0.98M	14.25M	-24.89M	-48.78M	-47.42M	-328.51M	401.14M	4.92M	24.13M	5.16M	-0.23M
Net Margin Growth (1y) (Quarter)	0.04M	-0.15M	-2.94M	-0.13M	-1.73M	-0.35M	2.51M	-0.75M	0.49M	0.51M	17.21M	-10.61M	-68.67M	-146.14M	-513.70M	-22.69M	33.47M	139.82M	496.71M	34.04M
Net Margin Growth (3y) (Quarter)								-0.92M	-1.20M	0.01M	16.78M	-11.49M	-69.90M	-145.98M	-493.98M	-34.05M	-34.70M	-5.81M	0.22M	0.74M
Net Margin Growth (5y) (Quarter)																-34.23M	-36.40M	-6.31M	-0.21M	-0.14M
Net Margin (QoQ) (Quarter)	0.08M	-0.16M	-2.56M	2.51M	-1.52M	1.22M	0.29M	-0.74M	-0.28M	1.23M	17.00M	-28.56M	-58.33M	-76.24M	-350.57M	462.44M	-2.17M	30.12M	6.32M	-0.23M
Operating Margin Growth (1y) (Quarter)	0.04M	-0.16M	-2.90M	-0.13M	-1.75M	-0.36M	2.46M	-0.79M	0.41M	0.52M	19.52M	-12.61M	-83.57M	-170.43M	-580.46M	-24.68M	45.27M	163.64M	561.17M	38.06M
Operating Margin Growth (3y) (Quarter)								-0.97M	-1.30M	0.00M	19.08M	-13.54M	-84.91M	-170.27M	-558.48M	-38.08M	-37.88M	-6.27M	0.23M	0.77M
Operating Margin Growth (5y) (Quarter)																-38.26M	-39.59M	-6.79M	-0.21M	-0.16M
Operating Margin (QoQ) (Quarter)	0.08M	-0.16M	-2.53M	2.48M	-1.54M	1.22M	0.30M	-0.78M	-0.33M	1.34M	19.30M	-32.91M	-71.29M	-85.53M	-390.73M	522.87M	-1.34M	32.84M	6.80M	-0.24M
Return on Assets Growth (1y) (Quarter)				0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (3y) (Quarter)												0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Assets Growth (5y) (Quarter)																				0.00M
Return on Assets (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Capital Employed Growth (1y) (Quarter)				-239.00	-0.00M	-982.00	-0.00M	-0.00M	-716.00	719.00	909.00	0.00M	0.00M	206.00	5.00	-0.00M	-0.00M	-0.00M	-138.00	361.00
Return on Capital Employed Growth (3y) (Quarter)												-330.00	-103.00	-56.00	-855.00	-0.00M	-0.00M	-0.00M	776.00	0.00M
Return on Capital Employed Growth (5y) (Quarter)																				-0.00M
Return on Capital Employed (QoQ) (Quarter)	186.00	-770.00	293.00	52.00	-924.00	-403.00	-494.00	-397.00	579.00	0.00M	-305.00	821.00	414.00	-723.00	-506.00	-581.00	-812.00	-806.00	0.00M	-82.00
Return on Equity Growth (1y) (Quarter)		-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (3y) (Quarter)										-1.00	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Equity Growth (5y) (Quarter)																		-1.00	0.00M	0.00M
Return on Equity (QoQ) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Return on Sales Growth (1y) (Quarter)	4.00	-15.00	-293.00	-13.00	-173.00	-35.00	251.00	-75.00	49.00	51.00	0.00M	-0.00M	-0.01M	-0.01M	-0.05M	-0.00M	0.00M	0.01M	0.05M	0.00M
Return on Sales Growth (3y) (Quarter)								-92.00	-120.00	1.00	0.00M	-0.00M	-0.01M	-0.01M	-0.05M	-0.00M	-0.00M	-580.00	22.00	74.00
Return on Sales Growth (5y) (Quarter)																-0.00M	-0.00M	-631.00	-21.00	-14.00
Return on Sales (QoQ) (Quarter)	8.00	-16.00	-256.00	251.00	-152.00	122.00	29.00	-74.00	-28.00	123.00	0.00M	-0.00M	-0.01M	-0.01M	-0.04M	0.05M	-208.00	0.00M	632.00	-23.00

Research Tools

Developers

4D Molecular Therapeutics Growth Metrics (2020-2026) | FDMT

Create an account

Sign In

Reset Password